Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-01550 | ||
It is originally isolated from Strptomyces sp. K385. Kitamycin A can inhibit the activity of plant growth. |
||
BBF-01553 | ||
It has the effect of resisting Marine gram-negative bacteria, but not against the marine gram-positive bacteria and general bacteria. |
||
BBF-01554 | ||
Kosinostatin is originally isolated from Paecilomyces sp. FO-3184. It showed strong anti-gram-positive bacterial activity (MIC of 0.039 μg/mL) and moderate anti-gram-negative bacterial and yeast activity (MIC of 1.56-12.5 μg/mL). It is also poisonous to the cells of a wide variety of tumor cells with the IC50 of 0.02-0.6 μmol/L. And the IC50 of inhibition of DNA topoisomerase IIα is 3-10 μmol/L. |
||
BBF-01558 | ||
YM-181741 is a novel benz[a]anthraquinone antibiotic isolated from the culture broth of actinomycete strain Q57219. It showed selective anti-Helicobacterpylori activity with a MIC value of 0.2 microg/ml. |
||
BBF-01559 | ||
YM-202204 is an antifungal antibiotic isolated from the culture broth of marine fungus Phoma sp. Q60596. It exhibited potent antifungal activities against Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus, and also inhibited glycosyl-phosphatidyl-inositol (GPI)-anchoring in yeast cells. |
||
BBF-01561 | ||
YM-266183 is a thiopeptide antibiotic produced by Bacillus cereus QN 03323. It exhibits antibacterial against staphylococci and enterococci, including MRSA and VRE. |
||
BBF-01562 | ||
YM-266184 is a thiopeptide antibiotic produced by Bacillus cereus QN 03323. It exhibits antibacterial against staphylococci and enterococci, including MRSA and VRE. |
||
BBF-01563 |
YN-0165J-A (102692-05-7) Inquiry |
|
YN-0165J-A is an enteromycin group antibiotic produced by Streptomyces strain YN-0165J. It is effective against Gram-positive and -negative bacteria, but is inactive to Enterobacter cloacae and Pseudomonas aeruginosa. |
||
BBF-01564 | ||
YS-822A is a polyene macrolide antibiotic isolated from the culture filtrate of a mutant strain H-8 of Streptoverticillium eurocidicum var. asterocidicus S-822. It has antifungal activity with MIC of 3.12-12.5μg/mL for yeast. |
||
BBF-01570 | ||
U-56407 is an antibiotic isolated from fermentations of Streptomyces hagronensis (strain 360). It is effective in vitro against Gram-positive bacteria but not Gram-negative organisms. |
||
BBF-01571 | ||
U-57930 is a group of nucleoside antibiotic isolated from Streptomyces rochei (NRRL-3533), which is against gram-positive bacteria and protozoon. |
||
BBF-01572 | ||
U-57930 is a group of nucleoside antibiotic isolated from Streptomyces rochei (NRRL-3533), which is against gram-positive bacteria and protozoon. |
||
BBF-01573 | ||
U-57930 is a group of nucleoside antibiotic isolated from Streptomyces rochei (NRRL-3533), which is against gram-positive bacteria and protozoon. |
||
BBF-01574 | ||
U-57930 is a group of nucleoside antibiotic isolated from Streptomyces rochei (NRRL-3533), which is against gram-positive bacteria and protozoon. |
||
BBF-01576 | ||
U-62162 is an antibiotic isolated from the fermentations of Streptomyces verdensis Dietz, sp. n. (UC-8157). It inhibited the growth of Gram-positive bacteria (particularly Staphylococcus aureus) but was inactive in experimentally infected animals. |
||
BBF-01580 | ||
UCA 1064-A is an antitumor antibiotic isolated from Wallemia sebi, which inhibits HeLa S3 cells with IC50 of 12.7 μmol/L, suppresses saccharomyces cerevisiae and gram-positive bacteria with MIC of 0.05 and 40 μg/mL, respectively. |
||
BBF-01581 | ||
UCA 1064-B is an antitumor antibiotic isolated from Wallemia sebi, which inhibits HeLa S3 cells with IC50 of 14.8 μmol/L, suppresses saccharomyces cerevisiae and gram-positive bacteria with MIC of 0.39 and 40 μg/mL, respectively. |
||
BBF-01590 | ||
UCH9 is an antitumor antibiotic produced Streptomyces. II. It exhibits bacteriophage and gram-positive bacteria activity. |
||
BBF-01591 | ||
UCS1025 A is an antitumor antibiotic isolated from Acremonium sp. KY4917. It exhibits activity against gram-positive bacteria including Staphylococcus and Enterococcus, and proteusbacillus vulgaris. It also inhibits cell proliferation. |
||
BBF-01592 | ||
UCS1025 B is an antitumor antibiotic isolated from Acremonium sp. KY4917. It exhibits activity against gram-positive bacteria including Staphylococcus and Enterococcus, and proteusbacillus vulgaris. It also inhibits cell proliferation. The activity of B is much weaker than that of A. |